Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy
- PMID: 27427762
- PMCID: PMC4948787
- DOI: 10.1371/journal.pone.0159347
Neutralizing Antibodies against Plasmodium falciparum Associated with Successful Cure after Drug Therapy
Abstract
An effective antibody response can assist drug treatment to contribute to better parasite clearance in malaria patients. To examine this, sera were obtained from two groups of adult patients with acute falciparum malaria, prior to drug treatment: patients who (1) have subsequent recrudescent infection, or (2) were cured by Day 28 following treatment. Using a Plasmodium falciparum antigen library, we examined the antibody specificities in these sera. While the antibody repertoire of both sera groups was extremely broad and varied, there was a differential antibody profile between the two groups of sera. The proportion of cured patients with antibodies against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 was higher than the proportion of patients with recrudescent infection. The presence of these antibodies was associated with higher odds of treatment cure. Sera containing all six antibodies impaired the invasion of P. falciparum clinical isolates into erythrocytes. These results suggest that antibodies specific against EXP1, MSP3, GLURP, RAMA, SEA and EBA181 in P. falciparum infections could assist anti-malarial drug treatment and contribute to the resolution of the malarial infection.
Conflict of interest statement
Figures

Similar articles
-
Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.Cell Microbiol. 2016 Dec;18(12):1739-1750. doi: 10.1111/cmi.12608. Epub 2016 May 27. Cell Microbiol. 2016. PMID: 27130708 Free PMC article.
-
Absence of in vivo selection for K13 mutations after artemether-lumefantrine treatment in Uganda.Malar J. 2017 Jan 9;16(1):23. doi: 10.1186/s12936-016-1663-1. Malar J. 2017. PMID: 28068997 Free PMC article.
-
Selection of Plasmodium falciparum pfcrt and pfmdr1 polymorphisms after treatment with artesunate-amodiaquine fixed dose combination or artemether-lumefantrine in Liberia.Malar J. 2016 Sep 5;15(1):452. doi: 10.1186/s12936-016-1503-3. Malar J. 2016. PMID: 27596849 Free PMC article. Clinical Trial.
-
Artemether-lumefantrine: an option for malaria.Ann Pharmacother. 2012 Apr;46(4):567-77. doi: 10.1345/aph.1Q539. Epub 2012 Apr 10. Ann Pharmacother. 2012. PMID: 22496476 Review.
-
Coartemether (artemether and lumefantrine): an oral antimalarial drug.Expert Rev Anti Infect Ther. 2004 Apr;2(2):181-96. doi: 10.1586/14787210.2.2.181. Expert Rev Anti Infect Ther. 2004. PMID: 15482185 Review.
Cited by
-
Development of New Strategies for Malaria Chemoprophylaxis: From Monoclonal Antibodies to Long-Acting Injectable Drugs.Trop Med Infect Dis. 2022 Apr 7;7(4):58. doi: 10.3390/tropicalmed7040058. Trop Med Infect Dis. 2022. PMID: 35448833 Free PMC article. Review.
-
Longitudinal analysis of antibody responses in symptomatic malaria cases do not mirror parasite transmission in peri-urban area of Cote d'Ivoire between 2010 and 2013.PLoS One. 2017 Feb 28;12(2):e0172899. doi: 10.1371/journal.pone.0172899. eCollection 2017. PLoS One. 2017. PMID: 28245264 Free PMC article.
-
A novel asexual blood-stage malaria vaccine candidate: PfRipr5 formulated with human-use adjuvants induces potent growth inhibitory antibodies.Front Immunol. 2022 Oct 27;13:1002430. doi: 10.3389/fimmu.2022.1002430. eCollection 2022. Front Immunol. 2022. PMID: 36389677 Free PMC article.
-
Immunogenicity and antigenicity of a conserved fragment of the rhoptry-associated membrane antigen of Plasmodium vivax.Parasit Vectors. 2022 Nov 15;15(1):428. doi: 10.1186/s13071-022-05561-8. Parasit Vectors. 2022. PMID: 36380374 Free PMC article.
-
To B or Not to B: Understanding B Cell Responses in the Development of Malaria Infection.Front Immunol. 2018 Dec 14;9:2961. doi: 10.3389/fimmu.2018.02961. eCollection 2018. Front Immunol. 2018. PMID: 30619319 Free PMC article. Review.
References
-
- WHO. Malaria factsheet. 2015; Available: http://www.cdc.gov/malaria/about/facts.html. Accessed 7 June 2016.
-
- Schofield L, Mueller I. Clinical immunity to malaria. Curr Mol Med. 2006;6: 205–221. Epub 2006/03/07. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources